W J Hogan
Overview
Explore the profile of W J Hogan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
258
Citations
4956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Begna K, Xu X, Gangat N, Alkhateeb H, Patnaik M, Al-Kali A, et al.
Blood Cancer J
. 2022 Apr;
12(4):55.
PMID: 35393398
No abstract available.
2.
Begna K, Kittur J, Gangat N, Alkhateeb H, Patnaik M, Al-Kali A, et al.
Blood Cancer J
. 2022 Jan;
12(1):7.
PMID: 35039473
We sought to appraise the value of overall response and salvage chemotherapy, inclusive of allogeneic hematopoietic stem cell transplant (AHSCT), in primary refractory acute myeloid leukemia (prAML). For establishing consistency...
3.
Hogan W, Punn R, Dean P, Strainic J, Rychik J, Williams R, et al.
Ultrasound Obstet Gynecol
. 2021 Sep;
59(5):682-686.
PMID: 34494326
The mitral-aortic intervalvular fibrosa (MAIVF) is an avascular, fibrous structure that provides continuity between the anterior leaflet of the mitral valve and the aortic valve. Pseudoaneurysm of the MAIVF is...
4.
Hogan W, Moon-Grady A, Zhao Y, Cresalia N, Nawaytou H, Quezada E, et al.
Ultrasound Obstet Gynecol
. 2020 Mar;
57(5):769-775.
PMID: 32202689
Objective: Fetal cerebrovascular resistance is influenced by several factors in the setting of intact autoregulation to allow for normal cerebral blood flow and oxygenation. Maternal hyperoxygenation (MH) allows for acute...
5.
Lehman J, Dasari S, Damodaran S, El-Azhary R, Gibson L, Hashmi S, et al.
Clin Exp Dermatol
. 2018 Oct;
44(4):e81-e88.
PMID: 30280423
Background: In both acute graft-versus-host disease (GVHD) and lupus erythematosus (LE), the patient's own tissues are subjected to immunological assault via complex mechanisms influenced by interferon (IFN) and other cytokines....
6.
Chakraborty R, Muchtar E, Kumar S, Buadi F, Dingli D, Dispenzieri A, et al.
Bone Marrow Transplant
. 2017 Nov;
53(2):155-161.
PMID: 29131152
The significance of elevated C-reactive protein (CRP) prior to autologous stem cell transplantation (ASCT) in multiple myeloma (MM) has not been studied. We analyzed 1111 MM patients who underwent ASCT...
7.
Kansagra A, Inwards D, Ansell S, Micallef I, Johnston P, Hogan W, et al.
Bone Marrow Transplant
. 2017 Oct;
53(2):146-154.
PMID: 29035394
The infusion of autograft absolute lymphocyte count (A-ALC) and autograft natural killer cells (A-NKC) are prognostic factors for overall survival (OS) and PFS in non-Hodgkin's lymphoma (NHL) patients undergoing autologous...
8.
Haddox C, Mangaonkar A, Chen D, Shi M, He R, Oliveira J, et al.
Blood Cancer J
. 2017 Oct;
7(9):e607.
PMID: 29016570
No abstract available.
9.
Dispenzieri A, Dsouza A, Gertz M, Laumann K, Wiseman G, Lacy M, et al.
Bone Marrow Transplant
. 2017 Sep;
52(10):1372-1377.
PMID: 28869617
This phase 1 study (clinical trial NCT00477815) was conducted to determine the maximum tolerated dose (MTD) of yttrium-90 ibritumomab tiuxetan (Y-Zevalin) with high dose melphalan (HDM) therapy in multiple myeloma...
10.
Chakraborty R, Muchtar E, Kumar S, Buadi F, Dingli D, Dispenzieri A, et al.
Leukemia
. 2017 Aug;
32(3):712-718.
PMID: 28848227
Post-transplant maintenance is widely used in multiple myeloma (MM); however, there is a lack of data on real-world outcomes. We have analyzed 577 patients with newly diagnosed MM undergoing early...